Scientists have long recognised a hereditary component to prostate cancer, a better understanding of which will lead to improved screening and outcomes for patients. The PHG Foundation is currently leading on the genetic strand of a European wide collaboration (COGS) to define individual risk of breast, ovarian, and prostate cancers, based on lifestyle factors and genetic variants. 

comments powered by Disqus

External links

Tags